Gerald Edelman advises on private equity healthcare transaction

Gerald Edelman is delighted to announce that its Corporate Finance team has advised the shareholders of Medical Imaging Systems Limited (“MIS”) on its investment from H2 Equity Partners (“H2”).

MIS, headquartered in London, is a leading medical equipment distributor and service provider focused on the diagnostic imaging market across the UK and the Republic of Ireland. MIS works with leading global equipment manufacturers in the supply of Ultrasound, Digital Radiography, MRI and CT equipment alongside related medical devices and consumables. MIS also provides a high-quality service and maintenance solution delivered through a national team of skilled engineers.

The existing shareholders have re-invested alongside H2 as part of this transaction and will continue to lead the business and work closely with H2 to deliver MIS’s ambitious growth strategy.

As well as being advised by Gerald Edelman’s Corporate Finance team, the shareholders were also advised from a legal perspective by Fladgate LLP.

Oliver Goldberg, Executive Director of MIS, commented:

“We are delighted to have completed this transaction with H2. As a family-run business, it was extremely important to find a partner that really understood the business and market. We truly believe that we have found this with H2, and we look forward to seeing what this partnership brings for the future.

I’d like to thank the Gerald Edelman team personally for the exceptional advice they provided throughout this process. Not only were they able to identify H2 as the right partner for us, but they also negotiated a great deal for all parties which will help propel MIS to the next level in the coming years. Their support allowed the team to focus on running the business, while they shouldered the burden of navigating a complex transaction. I wouldn’t hesitate to recommend Gerald Edelman to anyone thinking of raising investment or selling their business.”

Nick Wallis, Partner in Gerald Edelman’s Corporate Finance team, added:

“We are thrilled to have advised on an excellent deal for the shareholders of MIS. It has been a real pleasure to work with Oliver, Patrick and the rest of the MIS team throughout this transaction and we are confident that, with the help of H2, the business will continue to flourish.

As a family run and owned business, we understood the importance of finding the most suitable partner to help deliver the team’s vision for the future, and we are confident that they have found that in H2.

This transaction marks another successful completion for our Corporate Finance team and, whilst we remain sector agnostic, our experience in the healthcare sector continues to grow.

We wish the MIS team and H2 every success for the future.”